跳至主要内容
临床试验/TCTR20170408001
TCTR20170408001招募中未知

Effectiveness and Cost Effectiveness of a Combination HIV Preventive Intervention with and without daily oral Truvada® pre-exposure prophylaxis (PrEP) with adherence support among young men who have sex with men (YMSM) and transgender women (TGW) ag

S National Institutes of Health (NIH)0 个研究点目标入组 1,240 人开始时间: 2017年4月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
1,240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 26 Years(—)
性别
Male

入选标准

  • •Biological male sex at birth
  • •Self-report of having sold or traded sex to another man for money, drugs, or other goods or services in the previous 12 months.
  • •Age 18 through 26 years at enrollment
  • •Self-reported living in the greater Bangkok Metropolitan area or Pattaya City
  • •Willing to complete study instruments, with or without assistance, Thai and/or English.
  • •Thai citizenship
  • •Willing to provide contact and locator information
  • •Self-reported negative or unknown HIV status
  • •Negative rapid HIV test result at the screening visit

排除标准

  • •Unable or unwilling to provide consent for study participation
  • •Rapid HIV test results at the screening visit suggesting HIV infection
  • •Did not complete baseline assessment (Section 3.1 above)
  • •Any condition that would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
  • •Concurrently enrolled in another PrEP (oral or topical or injectable) intervention trial or preventive HIV vaccine trial.

研究者

发起方
S National Institutes of Health (NIH)

相似试验